AK Medical Holdings Limited disclosed a Next Day Disclosure Return to the Hong Kong Stock Exchange on 4 June 2026, detailing the latest movement in its share capital and buyback activity.

The company’s issued share capital stood unchanged at 1.12 billion ordinary shares as of 4 June 2026, with no treasury shares on hand.

On 4 June 2026, the group repurchased 1.00 million shares on the open market at prices ranging between HK$5.76 and HK$5.78, for a total consideration of HK$5.77 million. All repurchased shares are earmarked for cancellation.

Since the current buyback mandate was approved on 18 June 2025, AK Medical has bought back 13.56 million shares—12.08% of the shares outstanding on the mandate date—at prices spanning HK$5.72 to HK$7.00. The mandate allows for up to 112.27 million shares to be repurchased, leaving approximately 98.71 million shares still available.

A 30-day moratorium on new share issues or transfers is in effect until 4 July 2026 following the latest repurchase. The company affirmed that all buybacks complied with Hong Kong listing rules, were duly authorised by the board, and were fully settled in cash.